BioMarin Pharmaceutical develops and sells medicines for people with rare genetic diseases. It last closed at $60.41 on Nov 20, down 1.64% on the day. The next earnings report for BMRN is expected around Tue, Jan 5, 2027, after the close. For the quarter ended Sep 2026, BMRN reported EPS of -$0.63 on revenue of $1.02B, with revenue up 32.0% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months BMRN insiders bought $0 of stock on the open market and sold $4.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is BMRN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BMRN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BMRNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BMRN · as of the Nov 20 close · updated each morning
Turning up
The stock is 5% above its 20 day and 3% above its 50 day average. It is 3% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 59). The nearest support is the Pivot S1 at $59.49, and the nearest resistance the swing high (Jul 17) at $60.64.
Short trendBullish
Long trendNeutral
MomentumStrong
StretchNormal
VolatilityHigh, 3.3%/day
Key levels
$70.9852 week high+17.5%
$61.67Pivot R1+2.1%
$60.75Pivot+0.6%
$60.73100 day average+0.5%
$60.64Swing high (Jul 17)+0.4%
$60.41Last close
$59.49Pivot S1−1.5%
$58.92Swing low (Jul 31)−2.5%
$58.53200 day average−3.1%
$58.3250 day average−3.5%
$57.5920 day average−4.7%
$49.2652 week low−18.5%
Indicators
RSI (14)
59.30
Middle of its range
Neutral
MACD
0.68
Above its signal line
Bullish
Stochastic
81.9
Near the top of its range
Overbought
ADX (14)
19.3
No clear trend
Williams %R
-29.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
154.2
Oversold below −100, overbought above 100
Overbought
Rate of change
+7.8%
Change over 10 sessions
Bullish
ATR (14)
$1.99
Typical daily range, 3.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 7.1%/day
Key levels
$70.9852 week high+17.5%
$61.67Pivot R1+2.1%
$60.75Pivot+0.6%
$60.73100 day average+0.5%
$60.64Swing high (Jul 17)+0.4%
$60.41Last close
$59.49Pivot S1−1.5%
$58.92Swing low (Jul 31)−2.5%
$58.53200 day average−3.1%
$58.3250 day average−3.5%
$57.5920 day average−4.7%
$49.2652 week low−18.5%
Indicators
RSI (14)
52.95
Middle of its range
Neutral
MACD
-0.26
Below its signal line
Bearish
Stochastic
32.2
Middle of its range
Neutral
ADX (14)
21.1
Weak trend
Williams %R
-52.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-4.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.0%
Change over 10 sessions
Bearish
ATR (14)
$4.29
Typical daily range, 7.1% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Below
What happened before, for BMRN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BMRN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow BMRN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BMRNHow many large options trades hit BMRN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BMRN in the last 90 days.
From SEC Form 4 filings by BMRN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMRN is in one of them and how their past BMRN trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Biomarin Pharmaceutical
BioMarin Pharmaceutical develops and sells medicines for people with rare genetic diseases. Its products include VOXZOGO, a treatment for achondroplasia, the most common form of short stature caused by a genetic condition, and several enzyme therapies for conditions such as mucopolysaccharidosis and phenylketonuria. The company is based in California, and its customers are patients and the specialists who prescribe its treatments.